New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
09:59 EDTMDCO, NGLS, STKL, SO, SDRL, R, IMO, MDP, HBAN, EPDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Enterprise Products (EPD) downgraded to Hold from Buy at Jefferies... Huntington Bancshares (HBAN) downgraded to Outperform from Strong Buy at Raymond James... Imperial Oil (IMO) downgraded to Sell from Hold at Desjardins... Meredith (MDP) downgraded to Neutral from Buy at Citigroup... Ryder (R) downgraded to Hold from Buy at Stifel... Seadrill (SDRL) downgraded to Neutral from Buy at BofA/Merrill... Southern Company (SO) downgraded to Sector Perform from Outperform at RBC Capital... SunOpta (STKL) downgraded to Sell from Hold at Desjardins... Targa Resources Partners (NGLS) downgraded to Hold from Buy at Jefferies... The Medicines Co. (MDCO) downgraded to Market Perform from Outperform at Leerink.
News For EPD;HBAN;MDP;IMO;R;SDRL;SO;STKL;NGLS;MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 22, 2014
16:33 EDTROn The Fly: Closing Wrap
Subscribe for More Information
15:14 EDTRRyder weakness is a buying opportunity, says RBC Capital
Subscribe for More Information
09:45 EDTMDCOThe Medicines Co. says 'as open as can possibly be' to potential takeover
Subscribe for More Information
09:21 EDTMDCOThe Medicines Co. lowers 2014 revenue outlook to $720M-$735M
Subscribe for More Information
08:00 EDTRRyder expects to record non-cash pension settlement charge in Q4
Subscribe for More Information
07:57 EDTRRyder sees Q4 EPS $1.56-$1.61, consensus $1.59
Subscribe for More Information
07:57 EDTRRyder narrows FY14 comparable EPS view to $5.55-$5.60 from $5.50-$5.60
Subscribe for More Information
07:56 EDTRRyder reports Q3 comparable continuing ops EPS $1.63, consensus $1.63
Subscribe for More Information
07:11 EDTMDCOMedicines Co. says Angiomax, Angiox revenue up 5% in first nine months
Subscribe for More Information
07:06 EDTMDCOThe Medicines Co. reports Q3 EPS (26c) , consensus (12c)
Subscribe for More Information
October 21, 2014
15:35 EDTRNotable companies reporting before tomorrow's open
Subscribe for More Information
October 20, 2014
09:48 EDTMDCOBrdiger Management reports 5.1% passive stake in The Medicines Co.
08:41 EDTSDRLSeadrill downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
05:24 EDTSDRLSeadrill downgraded to Neutral from Buy at Citigroup
October 17, 2014
18:14 EDTEPDEnterprise Products extends open season for Bakken-to-Cushing pipeline
Enterprise Products Partners announced that the binding open commitment period to determine shipper demand for capacity on a proposed new crude oil pipeline from the Williston Basin of North Dakota to the Cushing hub in Oklahoma has been extended until 5 p.m. CST, November 14.
07:38 EDTHBANHuntington expects near-tern improvement in interest rate enviornment
The company says, "We continue to be pleased with our healthy lending pipeline and the strength of the economies within our footprint. We are looking forward to a solid finish for 2014, as we remain on track to deliver another year with positive operating leverage. We are not expecting a near-term improvement in the interest rate environment. However, we are committing to delivering positive operating leverage again in 2015 as we will continue to prudently manage expenses in alignment with our revenue growth outlook. Net interest income is expected to increase slightly in Q4. We anticipate an increase in earning assets as total loans moderately grow and investment securities increase modestly. However, those benefits to net interest income are expected to be partially offset by continued downward pressure on NIM. Noninterest income, excluding the impact of any net MSR activity, is expected to remain near the current quarter’s level. Noninterest expense, excluding Significant Items, is expected to remain near the current quarter’s adjusted level. Fourth quarter 2014 is expected to include approximately $10M of Significant Items related to the already announced franchise repositioning activities. We will continue to look for ways to reduce expenses, while not impacting our previously announced growth strategies and our high level of customer service. Overall, asset quality metrics are expected to remain near current levels, although moderate quarterly volatility also is expected, given the absolute low level of problem assets and credit costs. We anticipate NCOs will remain within or below our long-term normalized range of 35 to 55 basis points. The effective tax rate for the remainder of 2014 is expected to be in the range of 25%-28%, primarily reflecting the impacts of tax-exempt income, tax-advantaged investments, general business credits, and the change in accounting for investments in qualified affordable housing projects."
07:37 EDTHBANHuntington Bancshares reports Q3 net interest income $466.3M
Subscribe for More Information
07:34 EDTHBANHuntington Bancshares reports Q3 revenue $721.2M, consensus $716.43M
07:32 EDTHBANHuntington Bancshares ups dividend from 5c to 6c
Subscribe for More Information
07:31 EDTHBANHuntington Bancshares reports Q3 EPS 18c, consensus 19c
Reports Q3 net charge-offs declined to 0.26% of average loans and leases, down from 0.53% in the year-ago quarter.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use